| Literature DB >> 30213267 |
Uwe Ernsberger1, Hermann Rohrer2.
Abstract
Remarkable progress in a range of biomedical disciplines has promoted the understanding of the cellular components of the autonomic nervous system and their differentiation during development to a critical level. Characterization of the gene expression fingerprints of individual neurons and identification of the key regulators of autonomic neuron differentiation enables us to comprehend the development of different sets of autonomic neurons. Their individual functional properties emerge as a consequence of differential gene expression initiated by the action of specific developmental regulators. In this review, we delineate the anatomical and physiological observations that led to the subdivision into sympathetic and parasympathetic domains and analyze how the recent molecular insights melt into and challenge the classical description of the autonomic nervous system.Entities:
Keywords: Autonomic nervous system; Heart; Parasympathetic; Pelvic ganglion; Postganglionic; Preganglionic; Sacral; Sympathetic; Transcription factor
Mesh:
Substances:
Year: 2018 PMID: 30213267 PMCID: PMC6137933 DOI: 10.1186/s13064-018-0117-6
Source DB: PubMed Journal: Neural Dev ISSN: 1749-8104 Impact factor: 3.842
Selected subpopulations of postganglionic sympathetic neurons
| A) electrophysiologically defined subpopulations | |||||||
| Neuron class | MVC | CVC | SM | PM | |||
| Transmitter | NE | NE | ACH | NE | |||
| Peptide cat | NPY | NPY | VIP | ||||
| GAL | GAL | CGRP | GAL | ||||
| Peptide guinea pig | NPY | NPY | VIP | ||||
| DYN | CGRP | DYN | |||||
| major stimulus | |||||||
| human | baro-inhibition | cooling general | warming general | ||||
| cat | baro-inhibition | temperature | vibration | hypothalamic stimulation | (selected from [ | ||
| B) subpopulations defined by RNA sequencing | |||||||
| Neuron class | NA 1 | NA 2 | NA 3 | NA 4 | NA 5 | ACH 1 | ACH 2 |
| Average transcript number per cell | |||||||
| TH | 69 | 105 | 93 | 85 | 100 | 25 | 1 |
| DBH | 48 | 83 | 71 | 79 | 67 | 37 | 21 |
| DDC | 43 | 105 | 91 | 107 | 88 | 28 | 12 |
| VMAT 2 | 29 | 63 | 58 | 38 | 34 | 4 | 2 |
| CHAT | zero | zero | zero | zero | zero | 2 | 1 |
| VACHT | zero | zero | zero | zero | zero | 7 | 9 |
| NPY | 117 | 678 | 478 | 63 | 22 | 74 | 11 |
| SOM | zero | 1 | zero | zero | zero | 3 | 53 |
| VIP | 1 | 1 | 1 | zero | zero | 367 | 200 |
| CGRP (CALCA/B) | zero | zero | zero | zero | zero | 4/3 | 6/5 |
| defined target | erector | erector | |||||
| muscle | muscle | ||||||
| compiled from [ | |||||||
The table displays a selected set of sympathetic neurons derived from electrophysiological analysis (A) or from RNA sequencing profiles (B)
Electrophysiological analysis (A) defined a large number of sympathetic neuron classes named according to the target tissue supplied by the nerves from which recordings are made: MVC Muscle vasoconstrictor, SVC Skin vasoconstrictor, SM Sudomotor and PM Pilomotor among other populations not listed here. Classical neurotransmitters NE Norepinephrine and ACH Acetylcholine as well as neuropeptides detected in cat and guinea pig are provided for the individual neuron classes. In addition, the major stimuli detected by microneurography in humans and extracellular recording from prepared nerve filaments in cats are indicated to demonstrate the different reflex circuits and functional integration of the neuron classes
RNA sequencing profiles analyzed by unsupervised clustering algorithms (B) from material derived from stellate and thoracic mouse sympathetic ganglia disclosed a number of noradrenergic (NA 1 to 5) and cholinergic (ACH 1, 2) neuron populations distinguished by the preferential expression of certain genes. The numbers shown for the different genes give the average number of transcripts for the respective gene in a cell of a given population. Interestingly transcripts for noradrenergic markers TH Tyrosine hydroxylase, DBH Dopamine beta hydroxylase, DDC DOPA decarboxylase and the VMAT 2 Vesicular monoamine transporter 2 are not absent from the cholinergic neuron populations. On the other hand, cholinergic markers CHAT choline acetyltransferase and the VACHT Vesicular acetylcholine transporter are not detectable in the noradrenergic neuron populations. The NPY Neuropeptide is not absent from cholinergic neurons while SOM Somatostatin and VIP Vasoactive intestinal polypeptide are largely restricted to one or both cholinergic neuron populations. The targets given for the NA 2 and NA 5 are derived from developmental analysis and genetic labeling of specifically expressed genes. The high level SOM expression in ACH2 is characteristic for sudomotor neurons
Fig. 1Schematic illustration of the sympathetic neuron subtype differentiation in the mouse. BMP-signaling at the dorsal aorta elicits the expression of a group of transcription factors, including Phox2b, Hand2 and Gata3 [156–158, 221] that induce noradrenergic (Th, Dbh) and cholinergic genes (ChAT, VAChT), resulting in a high proportion of cells with a mixed noradrenergic/cholinergic phenotype at E10.5-E11.5 [143, 151]. At birth, the vast majority of postmitotic sympathetic neurons display noradrenergic properties; cholinergic characteristics are observed only in about 5% of sympathetic neurons [80, 151, 222]. Single-cell RNAseq of mature sympathetic neurons from P30 sympathetic ganglia allowed to define 2 subtypes of cholinergic sympathetic neurons (ACh1 and ACh2) (labeled by red cell bodies) and 5 subtypes of noradrenergic sympathetic neurons (NA1–5) (noradrenergic sympathetic neuron subtypes are labeled by different shades of blue) [80]. ACh1 and ACh2 correspond to previously identified sudomotor and periosteum-innervating neurons [85, 153]. NA2 and NA5 have been identified as nippleerector and piloerector sympathetic neurons. Sudomotor, NA2 and NA5 subtypes differentiate during postnatal development from noradrenergic neurons under the influence of target-derived differentiation signals [80, 87]. Vasoconstrictor, secretomotor, motility-regulating sympathetic neurons as well as other subtypes identified by physiological approaches are not yet characterized with respect to their gene expression signature and whether their differentiation is also controlled by target-derived signals
Fig. 2Transcriptional control of sympathetic neuron development. a Target genes regulated by Phox2b in sympathetic progenitors are detected in the Phox2b-knockout mouse [140]. Solid black arrows indicate complete absence of the indicated target genes in mutant embryos. In addition to the noradrenergic marker genes Th and Dbh (noradrenergic genes labeled by blue boxes), the cholinergic markers ChAT and VAChT (cholinergic genes labeled by red boxes) are not expressed in Phox2b mouse mutants [142]. Phox2b does not control initial expression of Ascl1 (white box). Expression of the transcription factor Hand2, which is required for Th and Dbh expression [223] depends on Phox2b [224]. Expression of Gata3, which increases Th transcript levels also depends on Phox2b [173]. Embryonic overexpression demonstrates that each of the transcription factors Phox2b, Phox2a, Hand2 and Gata3 is able to induce the expression of any of the other factors in progenitor cells [173, 225, 226] (blue stippled arrows). b In differentiated neurons different target genes are regulated by Phox2b as detected in conditional mutant mice deleting Phox2b after initial differentiation [152]. In differentiated sympathetic neurons Phox2b enhances its own expression but is dispensable for Phox2a and Hand2 yet remains required for Gata3 expression. Markers for the cholinergic phenotype as VAChT, Vip and Ret (cholinergic genes labeled by red boxes) appear independent of Phox2b, as well as the generic neuronal marker Tubb3 (generic neuronal genes are indicated by green boxes). On the other hand, peripherin (Prph) and Dbh depend on Phox2b. Hand2 remains required for Th and Dbh expression (noradrenergic genes labeled by blue boxes) in differentiated embryonic sympathetic neurons [149]. Notably, Hand2 elimination in adult sympathetic neurons reveals still another set of target-genes involved in synapse function [147]
Key regulators and their function in the development of the autonomic nervous system
| Cranial | Thoracolumbar | Sacral |
|---|---|---|
| Preganglionic neurons | ||
| Phox2b, Phox2aa | – | – |
| – | Olig2b | Olig2c |
| . | HoxC9d | nd |
| Tbx20e | – | – |
| – | FoxP1f | FoxP1g |
| – | Isl2h | nd |
| Postganglionic neurons | ||
| – | Gata3i | Gata3j |
| – | Hand1k | Hand1l |
| Hand2m | Hand2n | nd |
| – | HoxB8o | nd |
| Hmx1p | Hmx1q | nd |
| Hmx2 and 3r | -r | -r |
In this table transcriptional regulators are shown which are differentially expressed between preganglionic and postganglionic autonomic neurons at different levels of the rostrocaudal axis
aprogenitor domain specific expression [228]; neuronal differentiation, subtype specific marker expression [89, 229]; cell cycle exit promotion, controls migration to mantle layer [229]; pan neuronal induction, synchronization of subtype specification; repression of Olig 2 expression [175], neurite outgrowth, neuronal migration [176], promotion of TBX 20 and TBX 2 expression [152]; requirement for preganglionic neuron development [154]
bprogenitor domain specific expression; neuronal glial subtype choice [230, 231]; requirement for preganglionic neuron development [154]
crequirement for preganglonic neuron development [154]
dmRNA in embryonic mouse spinal cord caudal to T3; area of postmitotic cells [232]; protein in chick embryo; caudal brachial through thoracic; area of postmitotic cells [233]; expression in progenitors, differentiation requirement, neuronal migration [234]; axonal projection [235]; control of FoxP1 expression [235, 236]
eembryonic expression [154, 237]; cell migration [177]
fembryonic expression [154, 236]; segregation of motor neuron fates [236, 238]; axon projection [238]
gembryonic expression [154]
hexpression in somatic motoneurons (sm) but not in visceromotor (vm) or branchiomotor (bm) neurons in the hindbrain [227, 239, 240]; sm and vm/bm neurons at hindbrain levels are derived from different progenitors, whereas both are derived from the same progenitor in the spinal cord [212]; transient Isl2 expression required for preganglionic neuron development [212]
iexpression in embryonic mouse sympathetic ganglia [241]; differential expression in cranial parasympathetic versus sympathetic ganglia in mouse embryo [154]; lethality in mutant embryos, noradrenaline deficiency [242]; disturbed differentiation in mutant embryos [173, 225]; survival requirement in embryos and adult animals [174]
jexpression in pelvic ganglion [154]
kexpression in mouse SCG during embryonic, postnatal and adult stage, survival requirement, regulates TrkA expression [243]; embryonic expression in mouse sympathetic ganglia [154]
lexpression in embryonic pelvic ganglion [154]
mHand2 is expressed in the mouse sphenopalatine ganglion and is not connected to noradrenergic phenotype expression [147]; absence from majority of embryonic chick ciliary neurons [146, 148]
nexpression in chick sympathetic ganglia [244];cross-regulation with Phox2b, noradrenergic induction [226]; Hand1 induction [223, 245]; Th and Dbh induction [150, 223, 224]; maintenance of Th and Dbh expression [149]
oexpression in chick embryonic sympathetic ganglia, absence from embryonic chick ciliary ganglia, Hand2 induction in neural crest progenitors, Th and Dbh inductionin neural crest progenitors [148]
ptransient expression in mouse ciliary ganglion [246]
qmaintained expression in mouse sympathetic ganglia, required for TrkA expression, for Th maintenance, not for Vmat2 and Dbh [143]
rexpression in mouse parasympathetic ganglia but not in mouse sympathetic and pelvic ganglia [154]
nd Not determined
Fig. 3Preganglionic autonomic neurons, key transcription factors in their embryonic development and the classification of autonomic nervous system domains. The figure schematically displays the sympathetic and parasympathetic domains of autonomic preganglionic neurons and provides classical and recent naming proposals for the distinct subdivisions. These are derived primarily from physiological and pharmacological studies (Langley [1] see figure 1), evolutionary comparison within vertebrates (Nilsson [200], see figure 2) and developmental studies of critical regulators of neuronal cell lineage (Brunet and colleagues first presented in Espinosa–Medina et al., [154], see figure 4). The transcription factors responsible for the current renaming proposal from sacral “parasympathetic” to “sympathetic” are depicted above the schematic illustration of consecutive domains of the central nervous system harboring preganglionic autonomic neurons. The expression patterns and function are discussed in the main text and Table 2. The illustration is modified from Osumi and colleagues [227] with the mesencephalon containing the neuronal cell bodies giving rise to preganglionic axons to the IIIrd cranial nerve (N. oculomotorius) and the parasympathetic ciliary ganglion. The schematic illustration of the metencephalon displays rhombomeres 1 to 7 with the neuronal cell bodies giving rise to the visceromotor axons in the VIIth (N. facialis) and Xth (N. vagus) cranial nerves. The source of the Vth (N. trigeminus) and IXth nerve (N. glossopharyngeus) are omitted for simplicity. Within the thoracolumbar sympathetic domain, three different axon trajectories are indicated: leftward orientation indicating the rostral direction of preganglionic axons towards the SCG, rightward orientation towards more caudally located ganglia in the paravertebral sympathetic chains, and downward orientation indicating projection to prevertebral sympathetic ganglia. In the sacral autonomic domain at the right end of the scheme, axon projections indicate nerve fibers not entering the paravertebral sympathetic chain and traversing abdominal space in the N. pelvicus and pudentus